Beranda › Kanker Endometrium › Alaska › Anchorage
Uji klinis Kanker Endometrium di Anchorage, AK
4 studi untuk Kanker Endometrium mencari peserta di lokasi sekitar Anchorage (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Menerima pesertaFase 2
- Alaska Women's Cancer Care, Anchorage
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Menerima pesertaFase 3
- Alaska Women's Cancer Care, Anchorage
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Menerima pesertaFase 2
- Alaska Womens Cancer Care, Anchorage
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Menerima pesertaFase 3
- Alaska Women's Cancer Care ( Site 6036), Anchorage
Uji klinis Kanker Endometrium di kota lain
- Houston, TX68 studi
- New York City, NY52 studi
- Boston, MA50 studi
- Arlington, VA39 studi
- Nashville, TN38 studi
- Los Angeles, CA34 studi
- St. Louis, MO29 studi
- Philadelphia, PA28 studi
- San Antonio, TX27 studi
- Chicago, IL25 studi
- Columbus, OH25 studi
- Queens, NY25 studi
Studi lain di Anchorage
- Kanker Paru Non-Sel Kecil8 studi
- Kanker Ovarium7 studi
- Kanker Payudara7 studi
- Kanker Paru6 studi
- Kanker Prostat4 studi
- Kanker Pankreas4 studi
- Kanker (semua jenis)3 studi
- Melanoma3 studi
- Leukemia Biphenotypic Akut3 studi
- Kanker Lambung3 studi
- Kanker Esofagus3 studi
- Kanker Kolorektal3 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.